A Clinical Study to Evaluate MW33 Injection

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This randomized, double-blind, placebo-controlled, single-dose escalation trial will be conducted to evaluate the safety, tolerability, immunogenicity, pharmacokinetic and pharmacodynamic characteristics of a single dose of MW33 injection at different doses given to healthy subjects to provide a basis for exploration of the therapeutic and preventive effects of MW33 against neocoronavirus in human.
Epistemonikos ID: 04c5a67ccff1f9a30761c769e0d5eee9a29af9f8
First added on: Sep 01, 2020